KAM
VIVO

Keeley Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Keeley Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-82,375
Closed -$1.59M – 291
2016
Q3 		$1.59M Hold
82,375
– – 0.07% 161
2016
Q2 		$1.61M Sell
82,375
-6,900
-8% -$135K 0.07% 159
2016
Q1 		$1.84M Sell
89,275
-6,840
-7% -$135K 0.07% 155
2015
Q4 		$1.97M Sell
96,115
-15,500
-14% -$297K 0.06% 163
2015
Q3 		$1.91M Buy
111,615
+10,155
+10% +$186K 0.05% 192
2015
Q2 		$1.89M Buy
101,460
+8,950
+10% +$166K 0.04% 199
2015
Q1 		$1.76M Sell
92,510
-2,000
-2% -$37K 0.04% 221
2014
Q4 		$1.56M Sell
94,510
-3,400
-3% -$58.3K 0.03% 245
2014
Q3 		$1.73M Sell
97,910
-4,600
-4% -$90.4K 0.04% 246
2014
Q2 		$2.12M Sell
102,510
-5,100
-5% -$105K 0.04% 241
2014
Q1 		$2.35M Buy
107,610
+14,740
+16% +$338K 0.04% 235
2013
Q4 		$2.46M Buy
92,870
+5,400
+6% +$133K 0.04% 211
2013
Q3 		$2.07M Buy
87,470
+9,300
+12% +$217K 0.04% 222
2013
Q2 		$1.68M Buy
+78,170
New +$1.69M 0.03% 239

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Keeley Asset Management's VIVO Position: Q4 2016 in Review

Keeley Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q4 2016, closing a stake of 82,375 shares — an estimated $1.59M sold.

Keeley Asset Management first reported a position in VIVO in Q2 2013 and held it in 14 quarters. The position peaked at $2.46M in Q4 2013. 180 funds tracked by Wall St. Rank hold VIVO as of Q4 2016.

  • Keeley Asset Management reported no remaining Meridian Bioscience Inc position as of Q4 2016 after selling out during the quarter.
  • Keeley Asset Management sold 82,375 Meridian Bioscience Inc shares in Q4 2016, an estimated $1.59M.
  • Keeley Asset Management first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 14 quarters.
  • Keeley Asset Management's Meridian Bioscience Inc position peaked at $2.46M in Q4 2013.
  • 180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2016.

Based on Keeley Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.